Table 2.
Glucose (NA) | Myotubes |
Minced Skeletal Muscle, Protocol 4 | |||
---|---|---|---|---|---|
Protocol 2 | Protocol 3 | Medium | Glycogen | ||
C2D12 | 0.0049±0.0003 | 0.0052±0.0009 | 0.0053±0.0007 | 0.0049±0.0005 | ND |
C2D23 | 0.0053±0.0005 | 0.0051±0.0003 | 0.0053±0.0004 | 0.0050±0.0005 | ND |
C2Q | ND | ND | ND | ND (n = 8) | 0.4784±0.0788 (1.13) |
0.0009±0.0021 (0.0021) | |||||
C5D45 | 0.0056±0.0004 | 0.0051±0.0007 | 0.0054±0.0006 | 0.0052±0.0005 | ND |
C5D56 | 0.0057±0.0003 | 0.0051±0.0004* | 0.0052±0.0004* | 0.0051±0.0007 | ND |
C5Q | ND | 0.0057±0.0014 (0.0122) | 0.0065±0.0030 (0.0139) | ND (n = 6) | 0.6469±0.0441 (1.39) |
0.0014±0.0026 (0.0030) |
Values are means ± SE. 13C NMR analysis of MAG derived from NA glucose (n = 6), from medium glucose of myotubes (protocols 2–3, n = 6 for each), and from medium glucose (n = 10) and skeletal muscle glycogen (n = 6) in tissue incubation. Each value is the ratio of peak area of each resonance normalized by areas of methyl resonances of MAG on 13C NMR spectra (Aeach resonance/Amethyl). Nos. in parentheses are excess 13C enrichment (%). The protocols are described in the text and are summarized in the legend to Table 1. ND, not detectable.
Significantly different from NA glucose, P < 0.05.